Related Experiment Video

Updated: Jun 18, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Severe community-acquired infection caused by methicillin-resistant Staphylococcus aureus in Saudi Arabian children

Elham E Bukhari1, Fawzia E Al-Otaibi

  • 1Pediatric Department, King Khalid University Hospital, King Saud University, PO Box 7805, Riyadh 11472, Kingdom of Saudi Arabia. ebukhari@yahoo.com

Saudi Medical Journal
|November 26, 2009
PubMed

Insights

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are a serious threat to children in Saudi Arabia, causing severe invasive diseases. Early recognition and appropriate antimicrobial therapy are crucial for managing these challenging pediatric infections.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Microbiology

Background:

  • Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is a significant pathogen in pediatric populations.
  • CA-MRSA infections can lead to severe outcomes, including skin and soft tissue infections, necrotizing pneumonia, and sepsis.
  • Epidemiological data on invasive CA-MRSA infections in children in Saudi Arabia is limited.

Purpose of the Study:

  • To describe the clinical characteristics and outcomes of invasive CA-MRSA infections in previously healthy children in Saudi Arabia.
  • To highlight the challenges in diagnosing and treating severe CA-MRSA infections in pediatric patients.
  • To raise clinician awareness regarding the potential severity of CA-MRSA infections in children.

Main Methods:

  • Retrospective review of medical records of children with community-onset MRSA infections.
  • Identification and analysis of cases with invasive CA-MRSA infections between January 2005 and March 2008.
  • Clinical data including demographics, infection type, treatment, and outcomes were collected.

Main Results:

  • Five (6%) previously healthy children presented with invasive CA-MRSA infections out of 80 children with community-onset MRSA.
  • Infections included osteomyelitis, deep-seated infections, and severe orbital cellulitis with complications like subdural empyema.
  • Two patients received initial ineffective beta-lactam therapy; one isolate showed inducible clindamycin resistance.
  • All patients experienced uneventful recovery despite the severity of initial infections.

Conclusions:

  • Invasive CA-MRSA infections pose a significant threat to previously healthy children in Saudi Arabia.
  • Challenges exist in selecting appropriate antimicrobial therapy due to resistance patterns.
  • Increased clinical awareness and prompt, effective treatment are essential for managing severe pediatric CA-MRSA infections.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...